Features of myocardial characteristics of patients with acute ST-segment elevation myocardial infarction with diabetes mellitus as assessed by contrast-enhanced cardiac magnetic resonance imaging
Open Access
- 3 August 2023
- journal article
- research article
- Published by Remedium, Ltd. in Atherothrombosis
- Vol. 13 (1) , 58-72
Abstract
Introduction. The presence of diabetes mellitus in patients with acute infarction significantly worsens short- and long-term prognosis, but the features of the course of the infarction in this category of patients have not been fully studied.Objective. To compare clinical, functional and structural myocardial characteristics of patients with acute ST-segment elevation myocardial infarction with and without diabetes mellitus.Materials and methods. The study included 91 patients with revascularized ST-segment elevation myocardial infarction (41 patients with diabetes mellitus). All patients underwent cardiac MRI with contrast, including myocardial T1 mapping, tissue analysis of left ventricular myocardium with determination of infarct zone, heterogeneous zone, edema zone, pre- and post-contrast T1 values, extracellular volume values of healthy myocardium and infarct zone.Results. The presence of diabetes in patients with AMI was associated with increased EDV LV: 153 ± 38 and 181 ± 58 ml (p = 0.007), increased ESV LV: 76 ml [54–93] and 87 ml [71–122] (p = 0.035). Infarct size was significantly larger in patients with diabetes than in those without diabetes: 37 ± 15 g (95% CI: 33–41) and 47 ± 21 g (95% CI: 40–53), p = 0.017. Patients with acute infarction and diabetes mellitus had higher extracellular volume values in both healthy myocardium: 24% [22–27] and 28% [24–30], p = 0.002, and in the infarct zone: 48% [40–58] and 58% [50–61], p = 0.016.Conclusions. In patients with ST-segment elevation myocardial infarction with diabetes mellitus, the infarct size, the edema area, and the value of the extracellular volume fraction both in the infarct area and in the preserved myocardium were larger than in patients without diabetes, which may underlie the development of myocardial dysfunction and further progression of heart failure.Keywords
This publication has 22 references indexed in Scilit:
- Relationship Between Infarct Size and Outcomes Following Primary PCIJACC, 2016
- Myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping predicts ventricular arrhythmia in ischemic and non–ischemic cardiomyopathy patients with implantable cardioverter-defibrillatorsHeart Rhythm, 2015
- Effect of diabetes on scintigraphic infarct size in STEMI patients undergoing primary angioplastyDiabetes/Metabolism Research and Reviews, 2014
- Prognostic Value of Microvascular Obstruction and Infarct Size, as Measured by CMR in STEMI PatientsJACC: Cardiovascular Imaging, 2014
- Comparison of the Frequencies of Myocardial Edema Determined by Cardiac Magnetic Resonance in Diabetic Versus Nondiabetic Patients Having Percutaneous Coronary Intervention for ST Elevation Myocardial InfarctionThe American Journal of Cardiology, 2014
- Incidence and Prognostic Implication of Unrecognized Myocardial Scar Characterized by Cardiac Magnetic Resonance in Diabetic Patients Without Clinical Evidence of Myocardial InfarctionCirculation, 2008
- Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapyAmerican Heart Journal, 2007
- Comparison of Myocardial Reperfusion in Patients Undergoing Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction With Versus Without Diabetes Mellitus (from the EMERALD Trial)The American Journal of Cardiology, 2007
- Pharmacological Facilitation of Primary Percutaneous Coronary Intervention for Acute Myocardial InfarctionJAMA, 2005
- Impact of Diabetes on Mortality After the First Myocardial InfarctionDiabetes Care, 1998